United States: Getting The Best Out Of The EPO During The International Phase Of A PCT Application For US Applicants

Many US applicants using the Patent Cooperation Treaty (PCT) system designate the European Patent Office (EPO) as the International Searching Authority (ISA) to conduct the international search in Chapter I of the PCT procedure.  This decision carries with it certain consequences during the international phase, and during the national and regional phases thereafter.  Nevertheless, used properly, selecting the EPO as ISA, and optionally International Preliminary Examination Authority (IPEA) can give US applicants significant benefits.

The EPO is one of the six patent offices available to U.S. applicants as ISA.  The benefits to US applicants in selecting the EPO as ISA include:

  1. a complimentary search, to that obtained via the US Patent and Trademark Office (USPTO), that often considers non-US prior art in more detail; 
  2. a search opinion that reflects the approach to patentability taken by the EPO and more in line with many patent offices outside the US; 
  3. an EPO search on all claims, without the need to pay extra fees for claims in excess of 15;
  4. an exemption from payment of the EPO search fee during the regional phase; and
  5. potentially faster prosecution during the EPO regional phase. 

Both (1) and (2) above are provided without limit on the number of claims and without the significant fees payable for more than 15 claims in an application filed at the EPO.  In addition, electing the EPO as IPEA also leads to a reduction of 50% in the EPO examination fee due during the regional phase. 

These benefits mean that a US applicant can proceed to the national phase of a PCT application with a more informed view on the likelihood of success in the EPO and other countries with similar laws, which in turn may help expedite prosecution.  However, US applicants should keep in mind the potentially less desirable consequences that come with these benefits, as discussed below.

The EPO approach to unity of invention

The EPO examiners take a strict approach to unity of invention and limit searching to only those claims that together have the same special technical feature underlying the invention.  This manifests itself in two ways:

  1. the assessment of multiple independent claims in the same category but defining different features as being claims to different inventions (a priori lack of unity); and
  2. the case in which a broader, linking claim is found to lack novelty and there are several dependent claims, each covering different technical features (a posteriori lack of unity).

Both of these approaches can have a particular impact where a US-style claim set, involving multiple independent claims, or single claim dependencies for equivalent features.  In both cases, the applicant will be invited to pay further search fees and failure to do so will result in: 1) no search being performed on the second and subsequent inventions, 2) a requirement to delete the unsearched claims during the EPO regional phase, and 3) an inability to amend to any of the unsearched claims that are not unitary with the searched claims.  

The EPO's refusal to search certain subject matter

Methods of doing business, and methods of medical treatment are not patentable in the EPO.  EPO examiners are therefore allowed to refuse to search claims directed to these subjects, if no obvious technical subject matter can be seen.  Furthermore, even if a search is performed, the excluded subject matter is not considered limiting, leading to claims being given a very broad interpretation which can lead to the search being less useful for understanding potential scope of protection. 

The requirement to respond to the PCT search opinion early in EPO prosecution

If the claims presented in the EPO regional phase are the same as those presented at the PCT search phase, the EPO will treat the PCT search opinion as an EPO search opinion.  Namely the EPO will require the applicant to responds to the matters raised when indicating the intent to proceed with the application.  The invitation to respond will closely follow entry into the EPO regional phase and require a response within six months. 

Actions to improve the outcome

Applicants can take a number of actions that can mitigate against these less desirable consequences and still obtain the benefits of an EPO international search.  These include:

Filing an EPO-style claim set when filing the PCT application, with multiple dependencies and alternatives in claims; and limiting the number of independent claims.  Where multiple independent claims are necessary to define the invention, these need to be arranged such that the first independent claim provides a basis for the most relevant and broadest search.  This will tend to reduce the likelihood or impact of lack of unity issues,ensuring that the search covers all possible combinations of subject matter that may be required during prosecution to amend claim scope for allowability. 

Pay multiple search fees where lack of unity is alleged.  Even if it is not possible to include all claimed inventions in one national or regional phase application, any divisional applications can be based on an informed decision regarding patentability.  In the EPO, the search fee for the divisional application may be reduced or exempted based on the further PCT search.

Ensure that claims to methods of treatment, business methods, and the like appear after normal composition, apparatus, system or method of manufacture claims.  This strategy improves the chances that the search and opinion will focus on the core of the invention rather than being widely drawn and providing little guidance. 

In addition, it can be useful to use the possibility of international preliminary examination (IPE) under PCT Chapter II to address some of these issues, even if a positive outcome may be unlikely.  Even though the EPO may decline to examine second or subsequent inventions during the regional phase, when acting as IPEA, the EPO will examine all inventions for which international search fees and examination fees have been paid.  This can provide an applicant with better information for deciding which invention should be pursued in the EPO and other patent offices, and whether or not to file a divisional application.  A positive outcome during IPE will lead to the EPO phase application proceeding directly to grant.  It is also useful to remember that filing the demand for IPE does not oblige the applicant to proceed at the national phase with the claims on file at the end of IPE, they can still proceed with original claims.  This can be particularly useful if there are two possible lines of amendment or argument to address matters raised in the search.  Amending or arguing one of these during IPE then leaves the possibility of redirecting prosecution on entry the EPO regional phase to another without the risk of refusal of the examiner to exercise discretion and allow the new line to be presented. 

In all of these cases, it is useful to note that the PCT application as-filed is considered to be the EPO application and any amendments during the EPO phase will be judged against the original PCT application.  Thus, it is advisable to review the application before PCT filing to ensure that its content provides suitable support for likely amendments under EPO rules, as post-filing amendment possibilities are more limited.  Also, as IPE before the EPO is essentially similar to normal prosecution at the EPO, the use of a European patent attorney can be useful to avoid common issues due to differences in US and EPO procedure. 

With appropriate preparation and conduct, the EPO can provide a great benefit for US applicants seeking international patent protection via the PCT, without bringing unintended consequences due to differences in procedure.

This article previously appeared in Full Disclosure Patent Newsletter, September 2014.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
27 Nov 2017, Seminar, London, UK

Finnegan partner Anthony Tridico will present “U.S. Patent Case Law Update” at the Chartered Institute of Patent Attorneys’ annual Patent Case Law Review.

28 Nov 2017, Seminar, Milan, Italy

Finnegan partner John Paul will present “Internet of Things: Patent Liability, Enforcement and Licensing” and will join the Mock WIPO Mediation at International Technology Transfer—Licensing and ADR, co-hosted by Licensing Executives Society and World Intellectual Property Organization.

29 Nov 2017, Seminar, Tel Aviv, Israel

Finnegan is a platinum sponsor IVC Research Center’s start-up forum, “The Most Promising Start Ups for 2017 – A Synergy of Big Data, Artificial Intelligence, Machine Vision and IoT.”

 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.